(Q37763709)

22 August 2017

1 reference

title

Prostate cancer screening 2010: updated recommendations from the American Cancer Society (English)

1 reference

prostate cancer screening

22 August 2017

main subject

1 reference

1 reference

5

Idris Guessous

1 reference

22 August 2017

Durado D Brooks

1

1 reference

22 August 2017

Andrew Wolf

series ordinal

2

1 reference

22 August 2017

Robert A Smith

series ordinal

3

1 reference

22 August 2017

Chiranjeev Dash

series ordinal

4

1 reference

22 August 2017

publication date

1 May 2010

1 reference

Journal of the National Medical Association

22 August 2017

published in

1 reference

22 August 2017

volume

102

1 reference

22 August 2017

issue

5

1 reference

22 August 2017

page(s)

423-429

1 reference

Epidemiology and pathophysiology of prostate cancer in African-American men.

22 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0027-9684%2815%2930578-2

7 January 2021

Confirmation study of prostate cancer risk variants at 8q24 in African Americans identifies a novel risk locus.

1 reference

https://api.crossref.org/works/10.1016%2FS0027-9684%2815%2930578-2

7 January 2021

Racial differences in androgen receptor protein expression in men with clinically localized prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0027-9684%2815%2930578-2

7 January 2021

Explaining the race difference in prostate cancer stage at diagnosis

1 reference

https://api.crossref.org/works/10.1016%2FS0027-9684%2815%2930578-2

7 January 2021

Stage at diagnosis and survival in a multiethnic cohort of prostate cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0027-9684%2815%2930578-2

7 January 2021

Racial differences in initial treatment for clinically localized prostate cancer. Results from the prostate cancer outcomes study

1 reference

https://api.crossref.org/works/10.1016%2FS0027-9684%2815%2930578-2

7 January 2021

The influence of patient race and social vulnerability on urologist treatment recommendations in localized prostate carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0027-9684%2815%2930578-2

7 January 2021

American Cancer Society guideline for the early detection of prostate cancer: update 2010

1 reference

https://api.crossref.org/works/10.1016%2FS0027-9684%2815%2930578-2

7 January 2021

American Cancer Society guidelines for the early detection of cancer: update of early detection guidelines for prostate, colorectal, and endometrial cancers. Also: update 2001--testing for early lung cancer detection

1 reference

https://api.crossref.org/works/10.1016%2FS0027-9684%2815%2930578-2

7 January 2021

Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement

1 reference

https://api.crossref.org/works/10.1016%2FS0027-9684%2815%2930578-2

7 January 2021

Validation in a multiple urology practice cohort of the Prostate Cancer Prevention Trial calculator for predicting prostate cancer detection

1 reference

https://api.crossref.org/works/10.1016%2FS0027-9684%2815%2930578-2

7 January 2021

External validation of the Prostate Cancer Prevention Trial risk calculator in a screened population

1 reference

https://api.crossref.org/works/10.1016%2FS0027-9684%2815%2930578-2

7 January 2021

Assessing prostate cancer risk: results from the Prostate Cancer Prevention Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0027-9684%2815%2930578-2

7 January 2021

Prostate cancer detection in men with serum PSA concentrations of 2.6 to 4.0 ng/mL and benign prostate examination. Enhancement of specificity with free PSA measurements

1 reference

https://api.crossref.org/works/10.1016%2FS0027-9684%2815%2930578-2

7 January 2021

Serial prostate specific antigen screening for prostate cancer: a computer model evaluates competing strategies

1 reference

https://api.crossref.org/works/10.1016%2FS0027-9684%2815%2930578-2

7 January 2021

Comparative efficiency of prostate-specific antigen screening strategies for prostate cancer detection

1 reference

https://api.crossref.org/works/10.1016%2FS0027-9684%2815%2930578-2

7 January 2021

Prostate cancer mortality in relation to screening by prostate-specific antigen testing and digital rectal examination: a population-based study in middle-aged men.

1 reference

https://api.crossref.org/works/10.1016%2FS0027-9684%2815%2930578-2

7 January 2021

Population-based case-control study of PSA and DRE screening on prostate cancer mortality

1 reference

https://api.crossref.org/works/10.1016%2FS0027-9684%2815%2930578-2

7 January 2021

Screening by prostate-specific antigen and digital rectal examination in relation to prostate cancer mortality: a case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS0027-9684%2815%2930578-2

7 January 2021

The effectiveness of screening for prostate cancer: a nested case-control study.

1 reference

https://api.crossref.org/works/10.1016%2FS0027-9684%2815%2930578-2

7 January 2021

International trends in prostate-cancer mortality in the "PSA ERA".

1 reference

https://api.crossref.org/works/10.1016%2FS0027-9684%2815%2930578-2

7 January 2021

Screening, treatment, and prostate cancer mortality in the Seattle area and Connecticut: fifteen-year follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0027-9684%2815%2930578-2

7 January 2021

Natural experiment examining impact of aggressive screening and treatment on prostate cancer mortality in two fixed cohorts from Seattle area and Connecticut

1 reference

https://api.crossref.org/works/10.1016%2FS0027-9684%2815%2930578-2

7 January 2021

An ecologic study of prostate-specific antigen screening and prostate cancer mortality in nine geographic areas of the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0027-9684%2815%2930578-2

7 January 2021

Prostate cancer mortality after introduction of prostate-specific antigen mass screening in the Federal State of Tyrol, Austria

1 reference

https://api.crossref.org/works/10.1016%2FS0027-9684%2815%2930578-2

7 January 2021

Cancer surveillance series: interpreting trends in prostate cancer--part I: Evidence of the effects of screening in recent prostate cancer incidence, mortality, and survival rates.

1 reference

https://api.crossref.org/works/10.1016%2FS0027-9684%2815%2930578-2

7 January 2021

Implications of stage-specific survival rates in assessing recent declines in prostate cancer mortality rates

1 reference

https://api.crossref.org/works/10.1016%2FS0027-9684%2815%2930578-2

7 January 2021

Screening and prostate-cancer mortality in a randomized European study

1 reference

https://api.crossref.org/works/10.1016%2FS0027-9684%2815%2930578-2

7 January 2021

Mortality results from a randomized prostate-cancer screening trial

1 reference

https://api.crossref.org/works/10.1016%2FS0027-9684%2815%2930578-2

7 January 2021

Screening for prostate cancer--the controversy that refuses to die.

1 reference

https://api.crossref.org/works/10.1016%2FS0027-9684%2815%2930578-2

7 January 2021

Prostate cancer risk assessment program: a 10-year update of cancer detection

1 reference

https://api.crossref.org/works/10.1016%2FS0027-9684%2815%2930578-2

7 January 2021

Lead time and overdiagnosis in prostate-specific antigen screening: importance of methods and context

1 reference

https://api.crossref.org/works/10.1016%2FS0027-9684%2815%2930578-2

7 January 2021

Comparative effectiveness of minimally invasive vs open radical prostatectomy.

1 reference

https://api.crossref.org/works/10.1016%2FS0027-9684%2815%2930578-2

7 January 2021

Incidence of Late Rectal and Urinary Toxicities After Three-Dimensional Conformal Radiotherapy and Intensity-Modulated Radiotherapy for Localized Prostate Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0027-9684%2815%2930578-2

7 January 2021

Androgen deprivation therapy, insulin resistance, and cardiovascular mortality: an inconvenient truth

1 reference

https://api.crossref.org/works/10.1016%2FS0027-9684%2815%2930578-2

7 January 2021

Quality of life and satisfaction with outcome among prostate-cancer survivors

1 reference

https://api.crossref.org/works/10.1016%2FS0027-9684%2815%2930578-2

7 January 2021

Educating African American men about the prostate cancer screening dilemma: a randomized intervention

1 reference

https://api.crossref.org/works/10.1016%2FS0027-9684%2815%2930578-2

7 January 2021

Measurement of Prostate-Specific Antigen in Serum as a Screening Test for Prostate Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0027-9684%2815%2930578-2

7 January 2021

10.1016/S0027-9684(15)30578-2

Identifiers

DOI

0 references

1 reference